Loma Linda University School of Medicine has selected Daniel K. Rogstad, MD, PhD, as the new senior associate dean for medical student education.
Dr. Rogstad has had a distinguished career in both medicine and academia. He joined Loma Linda University School of Medicine in 2015 as assistant professor of medicine, and most recently served as associate dean of basic sciences education. He was instrumental in creating a learner-centered, integrated, organ-based model that supports the School of Medicine’s new Discovery Curriculum.
“I am confident that he will continue to inspire and guide our future medical professionals with the same passion and commitment he has shown throughout his career,” said Tamara Thomas, MD, dean of Loma Linda University School of Medicine. “His teaching methods and leadership in curriculum development have significantly enhanced the learning experience for our students.”
Dr. Rogstad has served as the course and thread director for Medical Biochemistry since 2015. He enjoys teaching biochemistry through team-based learning and the clinical application of foundational concepts. In addition to his role as an educator, and physician, he leads the Inland Empire’s only Coccidioidomycosis outpatient clinic.
Dr. Rogstad is a Loma Linda University alumnus earning a PhD in biochemistry in 2008, with an emphasis on oxidative DNA damage and repair, and his MD in 2009. He completed an internal medicine residency and an infectious diseases fellowship at Mayo Clinic Rochester, MN, including a two-year postdoctoral in molecular virology, studying the mechanisms of HIV and FIV (feline immunodeficiency virus) infection and host restriction factors.
He is board certified by the American Board of Internal Medicine in infectious disease and internal medicine.
He succeeds Tamara Shankel, MD, who served in this role since June 2017. Dr. Shankel will continue to contribute to medical education at Loma Linda University School of Medicine.
The position was approved by the Loma Linda University Health Board of Trustees in August 2024.